Citation

Horikawa M, Kato Y, Tyson CA, Sugiyama Y.: The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites. Drug Metab Pharmacokinet, Volume 17 (1), 2002

Authors

Horikawa M, Kato Y, Sugiyama Y., Tyson CA

Journal

Drug Metab Pharmacokinet

Year

2002

DOI

10.2133/dmpk.17.23

PubMed

15618649

Machine-readable

REST APIRDF